Treatment selection and
monitoring & MRD assessment.
FOR HEALTHCARE PROFESSIONALS
References: 1. Guardant360® CDx Technical Information. Guardant Health, Inc. Redwood City, CA. July 2021. 2. Guardant360 TissueNext™ Assay Specifications. Guardant Health, Inc. Redwood City, CA.
The liquid-only tests that detect minimal residual disease and assess molecular response to therapy.1,2
MONITORING AND MRD ASSESSMENT
A suite of revolutionary liquid and tissue tests to efficiently identify biomarker matched therapy.1,2
References: 1. Backgrounder: Guardant Reveal™ liquid biopsy test. Guardant Health, Inc. Redwood City, CA. 2. Guardant360® Response: Guide to ordering Guardant360 Response. Guardant Health, Inc. Redwood City, CA.
TREATMENT SELECTION
Reference: 1. Guardant Health data on file: Guardant Infinity Platform. Guardant Health, Inc. Redwood City, CA.
The platform that provides
epigenomic insights with cutting-edge methylation technology for our biopharma partners.1
FOR BIOPHARMA PARTNERS